CTXR
Citius Pharmaceuticals, Inc.
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The accompanying unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We incurred a net loss of $37,503,635 for the six months ended March 31, 2026. The Company experienced negative cash flows from operations of $14,308,843 for the six months ended March 31, 2026. At March 31, 2026, the Company had $4,590,174 in cash and a negative working capital of approximately $23.3 million.”View the 10-Q filed May 15, 2026
Company with tickers: CTXR
Market Cap
$14.96M
Shares Outstanding
27,452,570
CIK
1506251
CUSIP
17322U306
13F Activity (30d)
3 filings
2 filers
Website
Visit website
Investor Relations
Investor relations
Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K. Each badge shows which artefacts have landed.
| Period | Call date | Event | Artefacts | Open |
|---|---|---|---|---|
| FY2026 Q2 | 2026-05-15 | Citius Pharmaceuticals, Inc. Q2 FY2026 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2026 Q1 | 2026-02-13 | Citius Pharmaceuticals, Inc. Q1 FY2026 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2025 Q4 | 2025-12-23 | Citius Pharmaceuticals, Inc. Q4 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2025 Q3 | 2025-08-12 | Citius Pharmaceuticals, Inc. Q3 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2025 Q2 | 2025-05-14 | Citius Pharmaceuticals, Inc. Q2 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| Conference | 2025-01-29 | The MicroCap Conference 2025 |
Audio
Transcript
Slides
|
|
| Conference | 2025-01-29 | The MicroCap Conference 2025 |
Audio
Transcript
Slides
|
|
| FY2024 Q4 | 2024-12-27 | Citius Pharmaceuticals, Inc. Q4 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2024 Q3 | 2024-08-12 | Citius Pharmaceuticals, Inc. Q3 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2024 Q2 | 2024-05-14 | Citius Pharmaceuticals, Inc. Q2 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2024 Q1 | 2024-01-02 | Citius Pharmaceuticals, Inc. Q1 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2023 Q3 | 2023-08-15 | Citius Pharmaceuticals, Inc. Q3 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2023 Q2 | 2023-05-12 | Citius Pharmaceuticals, Inc. Q2 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2023 Q1 | 2023-02-10 | Citius Pharmaceuticals, Inc. Q1 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2022 Q4 | 2022-12-22 | Citius Pharmaceuticals, Inc. Q4 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2022 Q3 | 2022-08-11 | Citius Pharmaceuticals, Inc. Q3 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2022 Q2 | 2022-05-12 | Citius Pharmaceuticals, Inc. Q2 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2022 Q1 | 2022-02-10 | Citius Pharmaceuticals, Inc. Q1 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2021 Q4 | 2021-12-15 | Citius Pharmaceuticals, Inc. Q4 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2021 Q3 | 2021-08-12 | Citius Pharmaceuticals, Inc. Q3 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2021 Q2 | 2021-05-13 | Citius Pharmaceuticals, Inc. Q2 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
Showing 1–21 of 21 earnings calls